| Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM): a … M Attal, PG Richardson, SV Rajkumar, J San-Miguel, M Beksac, I Spicka, ... The Lancet 394 (10214), 2096-2107, 2019 | 686 | 2019 |
| The L-type calcium channel in the heart: the beat goes on I Bodi, G Mikala, SE Koch, SA Akhter, A Schwartz The Journal of clinical investigation 115 (12), 3306-3317, 2005 | 447 | 2005 |
| Isatuximab, carfilzomib, and dexamethasone in relapsed multiple myeloma (IKEMA): a multicentre, open-label, randomised phase 3 trial P Moreau, MA Dimopoulos, J Mikhael, K Yong, M Capra, T Facon, ... The Lancet 397 (10292), 2361-2371, 2021 | 349 | 2021 |
| Molecular determinants of Ca2+ channel function and drug action G Varadi, Y Mori, G Mikala, A Schwartz Trends in pharmacological sciences 16 (2), 43-49, 1995 | 278 | 1995 |
| Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial MA Dimopoulos, F Gay, F Schjesvold, M Beksac, R Hajek, KC Weisel, ... The Lancet 393 (10168), 253-264, 2019 | 268 | 2019 |
| Autologous haematopoietic stem cell mobilisation in multiple myeloma and lymphoma patients: a position statement from the European Group for Blood and Marrow Transplantation M Mohty, K Hübel, N Kröger, M Aljurf, J Apperley, GW Basak, ... Bone marrow transplantation 49 (7), 865-872, 2014 | 253 | 2014 |
| Molecular localization of ion selectivity sites within the pore of a human L-type cardiac calcium channel S Tang, G Mikala, A Bahinski, A Yatani, G Varadi, A Schwartz Journal of Biological Chemistry 268 (18), 13026-13029, 1993 | 213 | 1993 |
| Targeted disruption of the voltage-dependent calcium channel α2/δ-1-subunit GA Fuller-Bicer, G Varadi, SE Koch, M Ishii, I Bodi, N Kadeer, JN Muth, ... American Journal of Physiology-Heart and Circulatory Physiology 297 (1 …, 2009 | 172 | 2009 |
| Localization of the gene encoding the α2/δ-subunits of the L-type voltage-dependent calcium channel to chromosome 7q and analysis of the segregation of flanking markers in … DE Iles, F Lehmann-Horn, SW Scherer, LC Tsui, DO Weghuis, ... Human Molecular Genetics 3 (6), 969-975, 1994 | 172 | 1994 |
| Cloning, chromosomal localization, and functional expression of the alpha 1 subunit of the L-type voltage-dependent calcium channel from normal human heart. D Schultz, G Mikala, A Yatani, DB Engle, DE Iles, B Segers, RJ Sinke, ... Proceedings of the National Academy of Sciences 90 (13), 6228-6232, 1993 | 163 | 1993 |
| Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study S Verstovsek, AT Gerds, AM Vannucchi, HK Al-Ali, D Lavie, ... The Lancet 401 (10373), 269-280, 2023 | 146 | 2023 |
| Molecular pharmacology of voltage-dependent calcium channels Y Mori, G Mikala, G Varadi, T Kobayashi, S Koch, M Wakamori, ... The Japanese Journal of Pharmacology 72 (2), 83-109, 1996 | 132 | 1996 |
| Isatuximab plus pomalidomide and low-dose dexamethasone versus pomalidomide and low-dose dexamethasone in patients with relapsed and refractory multiple myeloma (ICARIA-MM … PG Richardson, A Perrot, J San-Miguel, M Beksac, I Spicka, X Leleu, ... The Lancet Oncology 23 (3), 416-427, 2022 | 112 | 2022 |
| Hypoxia inhibits the recombinant alpha 1C subunit of the human cardiac L‐type Ca2+ channel. IM Fearon, AC Palmer, AJ Balmforth, SG Ball, G Mikala, A Schwartz, ... The Journal of physiology 500 (3), 551-556, 1997 | 102 | 1997 |
| Motif III S5 of L-type calcium channels is involved in the dihydropyridine binding site: a combined radioligand binding and electrophysiological study M He, I Bodi, G Mikala, A Schwartz Journal of Biological Chemistry 272 (5), 2629-2633, 1997 | 101 | 1997 |
| Cardiac-specific Overexpression of the α1 Subunit of the L-type Voltage-dependent Ca2+ Channel in Transgenic Mice: LOSS OF ISOPROTERENOL-INDUCED CONTRACTION JN Muth, H Yamaguchi, G Mikala, IL Grupp, W Lewis, H Cheng, LS Song, ... Journal of Biological Chemistry 274 (31), 21503-21506, 1999 | 98 | 1999 |
| Differential contribution by conserved glutamate residues to an ion‐selectivity site in the L‐type Ca2+ channel pore G Mikala, A Bahinski, A Yatani, S Tang, A Schwartz FEBS letters 335 (2), 265-269, 1993 | 91 | 1993 |
| Auxiliary subunits operate as a molecular switch in determining gating behaviour of the unitary N‐type Ca2+ channel current in Xenopus oocytes M Wakamori, G Mikala, Y Mori The Journal of physiology 517 (3), 659-672, 1999 | 85 | 1999 |
| European data on stem cell mobilization with plerixafor in non-Hodgkin's lymphoma, Hodgkin's lymphoma and multiple myeloma patients. A subgroup analysis of the European … K Hübel, MM Fresen, JF Apperley, GW Basak, KW Douglas, IH Gabriel, ... Bone marrow transplantation 47 (8), 1046-1050, 2012 | 80 | 2012 |
| Inhibition of DNA binding by the phosphorylation of poly ADP-ribose polymerase protein catalysed by protein kinase C PI Bauer, G Farkas, L Buday, G Mikala, G Meszaros, E Kun, A Farago Biochemical and biophysical research communications 187 (2), 730-736, 1992 | 72 | 1992 |
Gyula VaradiBioPhysics Pharma, Inc.Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα b-physics.com
